425 Publications (Page 14 of 17)
2004
P1-356 Novel TNF-alpha inhibitors for neurodegeneration: 3-phthalimidoglutarimide analogues
Greig, Nigel H⋅Giordano, Tony⋅Zhu, Xiaoxiang⋅Yu, Qian-Sheng⋅Holloway, Harold W⋅Brossi, Arnold⋅Sambamurti, Kumar and Lahiri, Debomoy K
Neurobiology of Aging, vol. 25, pp. S199, 2004. | Journal Article
 
P1-414 Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers amyloid-beta peptide in rodents: a new treatment strategy for Alzheimer's disease
Greig, Nigel H⋅Utsuki, Tadanobu⋅Wang, Yue⋅Ingram, Donald K⋅Mamczar, Jacek⋅Rogers, Jack⋅Yun, Qian-Sheng⋅Holloway, Harold W⋅Perry, Tracy Ann⋅Sambamurti, Kumar⋅Scali, Carla⋅Pepeu, Giancarlo and Lahiri, Debomoy K
Neurobiology of Aging, vol. 25, pp. S216, 2004. | Journal Article
 
Preface: Current Research Trend on Neurodegeneration, Neuroinflammation, and Neuroprotection
Lahiri, Debomoy K
Annals of the New York Academy of Sciences, vol. 1035, (no. 1), pp. xiii, December 2004. | Journal Article
 
Preface: Scope of Current Alzheimer Research Debomoy
Lahiri, Debomoy
Current Alzheimer Research, vol. 1, (no. 2), pp. ii, 2004-05-01. | Journal Article
 
Presence of a "CAGA box" in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: implications in Alzheimer's disease.
Maloney, Bryan⋅Ge, Yuan-Wen⋅Greig, Nigel H and Lahiri, Debomoy K
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol. 18, (no. 11), pp. 1288-90, 2004/Aug. | Journal Article
 
Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents.
Lahiri, Debomoy K⋅Rogers, Jack T⋅Greig, Nigel H and Sambamurti, Kumar
Current pharmaceutical design. , vol. 10, (no. 25), pp. 3111-9, 2004. | Journal Article
 
Role of the APP promoter in Alzheimer's disease: cell type-specific expression of the beta-amyloid precursor protein.
Lahiri, Debomoy K and Ge, Yuan-Wen
Annals of the New York Academy of Sciences. , vol. 1030, pp. 310-6, 2004/Dec. | Journal Article
 
Role of the APP Promoter in Alzheimer's Disease: Cell Type-Specific Expression of the beta-Amyloid Precursor Protein
Lahiri, Debomoy K and Ge, Yuan-Wen
Annals of the New York Academy of Sciences, vol. 1030, pp. 310-316, 2004. | Journal Article
 
Role of the APP Promoter in Alzheimer's Disease: Cell Type‐Specific Expression of the β‐Amyloid Precursor Protein
Lahiri, Debomoy K and GE, YUAN‐WEN
Annals of the New York Academy of Sciences, vol. 1030, (no. 1), pp. 316, December 2004. | Journal Article
 
Thalidomide-based TNF- alpha inhibitors for neurodegenerative diseases
Greig, Nigel H⋅Giordano, Tony⋅Zhu, X.⋅Yu, Q-S⋅Perry, TA⋅Holloway, HW⋅Brossi, A.⋅Rogers, Jack T⋅Sambamurti, Kumar and Lahiri, Debomoy K
Acta Neurobiologiae Experimentalis, vol. 64, (no. 1), pp. 1-9, 2004. | Journal Article
 
Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases
Greig, Nigel H⋅Giordano, Tony⋅Zhu, Xiaoxiang⋅Yu, Qian-sheng⋅Perry, Tracy Ann⋅Holloway, Harold W⋅Brossi, Arnold⋅Rogers, Jack T⋅Sambamurti, Kumar and Lahiri, Debomoy K
Acta neurobiologiae experimentalis, vol. 64, (no. 1), pp. 1, 2004-00-00. | Journal Article
 
The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.
Venti, Amanda⋅Giordano, Tony⋅Eder, Paul⋅Bush, Ashley I⋅Lahiri, Debomoy K⋅Greig, Nigel H and Rogers, Jack T
Annals of the New York Academy of Sciences, vol. 1035, pp. 34-48, 2004/Dec. | Journal Article
 
The Integrated Role of Desferrioxamine and Phenserine Targeted to an Iron-Responsive Element in the APP-mRNA 5'-Untranslated Region
Venti, Amanda⋅Giordano, Tony⋅Eder, Paul⋅Bush, Ashley I⋅Lahiri, Debomoy K⋅Greig, Nigel H and Rogers, Jack T
Annals of the New York Academy of Sciences, vol. 1035, pp. 34-48, 2004. | Journal Article
 
Vaccinia Virus Complement Control Protein Reduces Inflammation and Improves Spinal Cord Integrity Following Spinal Cord Injury
REYNOLDS, DAVID N⋅Reynolds, David N⋅SMITH, SCOTT A⋅Smith, Scott A⋅Zhang, Yi P⋅ZHANG, YI P⋅MENGSHENG, QIU⋅Mengsheng, Qiu⋅Lahiri, Debomoy K⋅Lahiri, Debomoy K⋅MORASSUTTI, DANTE J⋅Morassutti, Dante J⋅Shields, Christopher B⋅SHIELDS, CHRISTOPHER B⋅KOTWAL, GIRISH J and Kotwal, Girish J
Annals of the New York Academy of Sciences, vol. 1035, (no. 1), pp. 178, December 2004. | Journal Article
2003
6th International Conference on Alzheimer's Disease and Parkinson's Disease.
Lahiri, Debomoy K
Expert opinion on investigational drugs. , vol. 12, (no. 8), pp. 1433-40, 2003/Aug. | Journal Article
 
A Critical Analysis of New Molecular Targets and Strategies for Drug Developments in Alzheimer's Disease
Lahiri, Debomoy K⋅Farlow, Martin R⋅Sambamurti, Kumar⋅Greig, Nigel H⋅Giacobini, E. and Schneider, Lon S
Current Drug Targets, vol. 4, (no. 2), pp. 97-112, 2003. | Journal Article
 
Addendum “APH1, PEN2, and Nicastrin increase Aβ levels and γ-secretase activity” [Biochem. Biophys. Res. Commun. 305 (2003) 502–509]
Marlow, Laura⋅Canet, Rosa M⋅Haugabook, Sharie J⋅Hardy, John A⋅Lahiri, Debomoy K and Sambamurti, Kumar
Biochemical and Biophysical Research Communications, vol. 307, (no. 3), pp. 756, 2003. | Journal Article
 
APH1, PEN2, and Nicastrin increase A beta levels and gamma -secretase activity
Marlow, L.⋅Canet, RM⋅Haugabook, SJ⋅Hardy, John⋅Lahiri, Debomoy K and Sambamurti, Kumar
Biochemical and Biophysical Research Communications, vol. 305, (no. 3), pp. 502-509, 2003. | Journal Article
 
APH1, PEN2, and Nicastrin increase Abeta levels and gamma-secretase activity
Marlow, Laura⋅Marlow, Laura⋅Canet, Rosa M⋅Canet, Rosa M⋅Haugabook, Sharie J⋅Haugabook, Sharie J⋅Hardy, John A⋅Hardy, John⋅Lahiri, Debomoy K⋅Lahiri, Debomoy K⋅Sambamurti, Kumar and Sambamurti, Kumar
Biochemical and biophysical research communications, vol. 305, (no. 3), pp. 502, 2003-Jun-06. | Journal Article
 
A proximal gene promoter region for the beta-amyloid precursor protein provides a link between development, apoptosis, and Alzheimer's disease.
Lahiri, Debomoy K⋅Ghosh, C and Ge, Y-W
Annals of the New York Academy of Sciences. , vol. 1010, pp. 643-7, 2003/Dec. | Journal Article
 
Does nitric oxide synthase contribute to the pathogenesis of Alzheimer's disease?: effects of beta-amyloid deposition on NOS in transgenic mouse brain with AD pathology.
Lahiri, Debomoy K⋅Chen, D⋅Ge, Y-W⋅Farlow, M⋅Kotwal, G⋅Kanthasamy, A⋅Ingram, D K and Greig, N H
Annals of the New York Academy of Sciences. , vol. 1010, pp. 639-42, 2003/Dec. | Journal Article
 
Glucagon-like peptide-1 decreases endogenous amyloid- beta peptide (A beta ) levels and protects hippocampal neurons from death induced by A beta and iron
Perry, T.⋅Lahiri, Debomoy K⋅Sambamurti, Kumar⋅Chen, D.⋅Mattson, MP⋅Egan, JM and Greig, NH
Journal of Neuroscience Research, vol. 72, (no. 5), pp. 603-612, 2003. | Journal Article
 
Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.
Perry, TracyAnn⋅Lahiri, Debomoy K⋅Sambamurti, Kumar⋅Chen, Demao⋅Mattson, Mark P⋅Egan, Josephine M and Greig, Nigel H
Journal of neuroscience research, vol. 72, (no. 5), pp. 603-12, 2003/Jun/1. | Journal Article
 
Review: cholinesterase inhibitors have a modest effect on neuropsychiatric and functional outcomes in Alzheimer's disease
Lahiri, Debomoy K⋅Lahiri, Debomoy K⋅Farlow, Martin R and Farlow, Martin R
Evidence-based mental health, vol. 6, (no. 3), pp. 94, 2003-Aug. | Journal Article
 
Role of cytokines in the gene expression of amyloid beta -protein precursor: Identification of a 5'-UTR-Binding nuclear factor and its implications in Alzheimer's disease
Lahiri, Debomoy K⋅Chen, D.⋅Vivien, D.⋅Ge, Y-W⋅Greig, Nigel H and Rogers, Jack T
Journal of Alzheimer's Disease, vol. 5, (no. 2), pp. 81-90, 2003. | Journal Article